Ngm Biopharmaceuticals Net Tangible Assets

Ngm Biopharmaceuticals (NGM) currently reports a net tangible assets of $150M as of December 2023. That compares with $260M in the prior-year period — down 42.7% year over year. Use the charts on this page to explore Ngm Biopharmaceuticals's net tangible assets history and peer comparisons.

Ngm Biopharmaceuticals's net tangible assets decreased from $260M to $150M — a 42.7% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ngm Biopharmaceuticals reported $150M in net tangible assets as of December 2023. That compares with $260M in the prior-year period — down 42.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $150M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ngm Biopharmaceuticals, and consider following NGM for alerts when major investors trade the stock.

Ngm Biopharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $150M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NGM with unrelated industries.